• Research Topics

  Bookmark this webinar: Biomarker Study of Edaravone (Radicava)

  Posted by Dagmar on November 12, 2019 at 2:51 pm

  The webinar will review edaravone evidence, talk about the use of biomarkers to understand the effect of medical therapies, present the design of the REFINE-ALS study, and discuss how people can get involved in the study.

  REFINE-ALS: A Much-Needed Biomarker Study of Edaravone (Radicava) in ALS

  James D. Berry, MD, MPH, Massachusetts General Hospital

  Thursday, November 14, 2019  

      4:00 – 5:00 PM EST

  Register/watch webinar here.

  Note: if you miss the webinar, we will post a link to the replay once it is available.

   

   

   

  Dagmar replied 4 years, 5 months ago 1 Member · 0 Replies

  • ALS clinical trials
  • ALS research
  • Biomarkers. Edaravone
  • Radicavava
  • research
• 0 Replies

Log In to Reply